Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | APGE |
---|---|---|
09:32 ET | 2026 | 52 |
09:34 ET | 104 | 51.98 |
09:39 ET | 446 | 51.98 |
09:41 ET | 500 | 51.695 |
09:45 ET | 300 | 51.3 |
09:48 ET | 100 | 51.22 |
09:50 ET | 200 | 51.71 |
09:52 ET | 400 | 51.58 |
09:54 ET | 100 | 51.53 |
09:56 ET | 500 | 51.54 |
09:57 ET | 100 | 51.52 |
09:59 ET | 1646 | 51.75 |
10:01 ET | 100 | 51.84 |
10:03 ET | 100 | 51.74 |
10:06 ET | 300 | 51.95 |
10:12 ET | 200 | 52.17 |
10:14 ET | 100 | 52.195 |
10:15 ET | 400 | 52.27 |
10:17 ET | 500 | 52.235 |
10:19 ET | 400 | 52.13 |
10:21 ET | 500 | 52.04 |
10:26 ET | 900 | 52.02 |
10:28 ET | 1000 | 52.05 |
10:30 ET | 1670 | 51.67 |
10:32 ET | 449 | 51.85 |
10:33 ET | 1578 | 52.35 |
10:35 ET | 200 | 51.97 |
10:37 ET | 400 | 51.885 |
10:39 ET | 400 | 51.99 |
10:42 ET | 1709 | 51.935 |
10:46 ET | 200 | 51.93 |
10:48 ET | 500 | 51.87 |
10:50 ET | 300 | 51.59 |
10:53 ET | 700 | 51.42 |
10:55 ET | 1020 | 51.51 |
10:57 ET | 500 | 51.62 |
11:02 ET | 100 | 51.31 |
11:04 ET | 300 | 51.56 |
11:06 ET | 233 | 51.4 |
11:08 ET | 563 | 51.555 |
11:09 ET | 200 | 51.69 |
11:11 ET | 100 | 51.465 |
11:15 ET | 100 | 51.48 |
11:20 ET | 100 | 51.57 |
11:22 ET | 100 | 51.61 |
11:24 ET | 1000 | 51.63 |
11:26 ET | 400 | 51.79 |
11:27 ET | 300 | 52.08 |
11:29 ET | 600 | 51.985 |
11:31 ET | 700 | 52 |
11:36 ET | 100 | 52.125 |
11:38 ET | 100 | 52.12 |
11:40 ET | 250 | 52.13 |
11:42 ET | 3482 | 51.975 |
11:44 ET | 300 | 52.08 |
11:45 ET | 900 | 51.9201 |
11:47 ET | 1400 | 52.01 |
11:49 ET | 400 | 52.015 |
11:58 ET | 1000 | 51.835 |
12:00 ET | 11003 | 51.845 |
12:02 ET | 3524 | 51.765 |
12:03 ET | 1046 | 51.735 |
12:05 ET | 400 | 51.86 |
12:07 ET | 1000 | 52.04 |
12:09 ET | 500 | 51.945 |
12:18 ET | 591 | 51.755 |
12:20 ET | 4153 | 51.905 |
12:21 ET | 2327 | 51.9 |
12:23 ET | 900 | 52.015 |
12:25 ET | 2092 | 51.79 |
12:27 ET | 6009 | 51.86 |
12:30 ET | 2922 | 52.065 |
12:36 ET | 750 | 52.19 |
12:38 ET | 288 | 52.3099 |
12:41 ET | 500 | 52.22 |
12:43 ET | 100 | 52.22 |
12:50 ET | 400 | 52.055 |
12:54 ET | 128 | 51.92 |
12:56 ET | 800 | 52.05 |
12:57 ET | 200 | 52.05 |
12:59 ET | 200 | 52.23 |
01:01 ET | 700 | 52.23 |
01:06 ET | 300 | 52.1295 |
01:08 ET | 730 | 52.2 |
01:10 ET | 200 | 52.03 |
01:14 ET | 4208 | 52 |
01:15 ET | 759 | 52.135 |
01:17 ET | 100 | 52.11 |
01:19 ET | 100 | 52.28 |
01:26 ET | 400 | 52.43 |
01:33 ET | 200 | 52.18 |
01:35 ET | 600 | 52.13 |
01:37 ET | 899 | 52.28 |
01:42 ET | 1180 | 52.175 |
01:44 ET | 1900 | 52.0406 |
01:46 ET | 25953 | 51.82 |
01:48 ET | 2500 | 51.62 |
01:50 ET | 1662 | 51.56 |
01:53 ET | 139 | 51.62 |
01:55 ET | 300 | 51.57 |
01:57 ET | 880 | 51.34 |
02:00 ET | 100 | 51.245 |
02:02 ET | 100 | 51.215 |
02:04 ET | 1948 | 51.53 |
02:11 ET | 600 | 51.69 |
02:18 ET | 100 | 51.7 |
02:20 ET | 100 | 51.43 |
02:22 ET | 400 | 51.49 |
02:24 ET | 2200 | 51.49 |
02:26 ET | 200 | 51.5 |
02:27 ET | 400 | 51.6 |
02:29 ET | 1614 | 51.51 |
02:31 ET | 375 | 51.4 |
02:38 ET | 4300 | 51.36 |
02:40 ET | 550 | 51.41 |
02:42 ET | 100 | 51.46 |
02:49 ET | 2000 | 51.33 |
02:51 ET | 1500 | 51.1715 |
02:54 ET | 400 | 51.04 |
02:58 ET | 500 | 50.75 |
03:03 ET | 1304 | 51.18 |
03:07 ET | 2343 | 50.752 |
03:12 ET | 200 | 50.7 |
03:16 ET | 200 | 50.77 |
03:18 ET | 100 | 50.71 |
03:20 ET | 300 | 50.47 |
03:23 ET | 300 | 50.42 |
03:27 ET | 1353 | 50.33 |
03:30 ET | 898 | 50.63 |
03:38 ET | 1300 | 50.535 |
03:43 ET | 2585 | 50.73 |
03:45 ET | 687 | 50.575 |
03:48 ET | 700 | 50.445 |
03:52 ET | 1216 | 50.64 |
03:54 ET | 2576 | 50.68 |
03:56 ET | 500 | 50.67 |
03:57 ET | 2574 | 50.66 |
03:59 ET | 30662 | 50.64 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Apogee Therapeutics Inc | 3.0B | -22.6x | --- |
Xenon Pharmaceuticals Inc | 3.0B | -14.6x | --- |
Iovance Biotherapeutics Inc | 3.0B | -6.2x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
MoonLake Immunotherapeutics | 3.2B | -56.4x | --- |
Celldex Therapeutics Inc | 2.8B | -15.0x | --- |
Apogee Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immunology (I&I) indications with high unmet need. Its advanced programs are APG777 and APG808, which are developed for the treatment of AD and COPD, respectively. APG777 is a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) targeting IL-13. APG808 is an SQ extended half-life mAb targeting IL-4Rα. Its earlier-stage programs, APG990 and APG222, utilize advanced antibody engineering to target OX40L and both IL-13 and OX40L, which are developed for the treatment of AD. APG990 is an SQ extended half-life mAb targeting OX40L for the treatment of AD. APG222 is one or more extended half-life SQ antibodies targeting both IL-13 and OX40L, which has the potential to improve outcomes in AD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.0B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.25 |
Book Value | $7.86 |
P/E Ratio | -22.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.